Related Experiment Video
Updated: Jul 5, 2026
14:57
Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
In vitro hepatoprotective compounds from Suaeda glauca
Ren-Bo An1, Dong-Hwan Sohn, Gil-Saeng Jeong
1College of Pharmacy, Yanbian University, Yanji, Jilin, 133000, China.
Archives of Pharmacal Research
|May 16, 2008
Summary
This study identified four phenolic compounds from Suaeda glauca. Two compounds, methyl 3,5-di-O-caffeoyl quinate and 3,5-di-O-caffeoyl quinic acid, demonstrated significant hepatoprotective effects in liver cells.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Hepatoprotective Agents
Background:
- Suaeda glauca is a plant species with potential medicinal properties.
- Hepatotoxicity, or liver damage, is a significant health concern.
- Phenolic compounds are known for their diverse biological activities.
Purpose of the Study:
- To isolate and identify bioactive compounds from Suaeda glauca.
- To evaluate the hepatoprotective potential of isolated compounds against drug-induced liver injury.
Main Methods:
- Bioassay-guided fractionation of the methanol extract of Suaeda glauca.
- Isolation and structural elucidation of four phenolic compounds.
- Assessment of hepatoprotective activity using Hep G2 cells and tacrine-induced cytotoxicity assay.
Main Results:
- Four phenolic compounds were isolated: methyl 3,5-di-O-caffeoyl quinate (1), 3,5-di-O-caffeoyl quinic acid (2), isorhamnetin 3-O-beta-D-galactoside (3), and quercetin 3-O-beta-D-galactoside (4).
- Compounds 1 and 2 exhibited significant hepatoprotective effects against tacrine-induced cytotoxicity in Hep G2 cells.
- The EC50 values for compounds 1 and 2 were 72.7±6.2 µM and 117.2±10.5 µM, respectively, compared to the positive control silybin (82.4±4.1 µM).
Conclusions:
- Suaeda glauca is a source of phenolic compounds with notable hepatoprotective properties.
- Methyl 3,5-di-O-caffeoyl quinate and 3,5-di-O-caffeoyl quinic acid show promise as therapeutic agents for liver protection.
- Further research is warranted to explore the mechanisms of action and therapeutic applications of these compounds.
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:24Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...